#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	17278	16S	1529	1529	99.93	16S.l15.c17.ctg.1	2521	842.9	0	.	n	.	0	C1450T	SNP	1450	1450	C	1894	1894	T	1128	T,G,C	1124,3,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	17278	16S	1529	1529	99.93	16S.l15.c17.ctg.1	2521	842.9	1	SNP	n	C1184T	0	.	.	1184	1184	C	1628	1628	C	1065	C	1065	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	29730	23S	2890	2890	99.86	23S.l15.c17.ctg.1	4205	882.9	0	.	n	.	0	T695C	SNP	695	695	T	1290	1290	C	1105	C,T,G,A	1100,2,2,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	29730	23S	2890	2890	99.86	23S.l15.c17.ctg.1	4205	882.9	0	.	n	.	0	A1638G	SNP	1638	1638	A	2233	2233	G	1050	G	1050	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	29730	23S	2890	2890	99.86	23S.l15.c17.ctg.1	4205	882.9	0	.	n	.	0	T1971C	SNP	1971	1971	T	2566	2566	C	998	C,G,T,A	993,1,2,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	29730	23S	2890	2890	99.86	23S.l15.c17.ctg.1	4205	882.9	0	.	n	.	0	C2194T	SNP	2194	2194	C	2789	2789	T	956	T,C,A	952,2,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	29730	23S	2890	2890	99.86	23S.l15.c17.ctg.1	4205	882.9	1	SNP	n	A2045G	0	.	.	2045	2045	A	2640	2640	A	980	A,G,C	978,1,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	29730	23S	2890	2890	99.86	23S.l15.c17.ctg.1	4205	882.9	1	SNP	n	C2597T	0	.	.	2597	2597	C	3192	3192	C	1012	C,T,A	1010,1,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	29730	23S	2890	2890	99.86	23S.l15.c17.ctg.1	4205	882.9	0	HET	.	.	.	T191C	.	191	191	T	786	786	T	1126	T,C	600,526	.	.
folP.WHO_F_01537c	folP.WHO_F_01537c	1	1	27	2426	folP	852	852	100.0	folP.l6.c4.ctg.1	2023	149.6	1	SNP	p	R228S	0	.	.	682	684	CGC	1223	1225	CGC	239;238;240	C;G,C;C	239;237,1;240	folP.WHO_F_01537c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5716	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3975	179.7	1	SNP	p	S91F	0	.	.	271	273	TCC	886	888	TCC	204;207;208	T;C;C	204;207;208	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5716	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3975	179.7	1	SNP	p	D95G	0	.	.	283	285	GAC	898	900	GAC	213;216;216	G,T;A;C,A	212,1;216;215,1	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5716	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3975	179.7	1	SNP	p	D95N	0	.	.	283	285	GAC	898	900	GAC	213;216;216	G,T;A;C,A	212,1;216;215,1	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_M_01390	mtrR.WHO_M_01390	1	1	27	2216	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1845	149.8	1	SNP	p	G45D	1	.	.	133	135	GAC	726	728	GAC	251;249;253	G;A,T;C	251;248,1;253	mtrR.WHO_M_01390:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	1140	mtrR_promoter	250	250	99.2	mtrR_promoter.l15.c4.ctg.1	1557	91.4	0	.	n	.	0	T10C	SNP	10	10	T	661	661	C	197	C	197	.	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	1140	mtrR_promoter	250	250	99.2	mtrR_promoter.l15.c4.ctg.1	1557	91.4	0	.	n	.	0	A197.	DEL	197	197	A	847	847	A	223	A	223	.	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	5758	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3610	199.2	0	.	p	.	0	V384I	NONSYN	1150	1152	GTC	1760	1762	ATC	222;223;224	A;T,C;C	222;222,1;224	.	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	5758	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3610	199.2	0	.	p	.	0	V435A	NONSYN	1303	1305	GTG	1913	1915	GCA	263;264;265	G,T;C;A,G	262,1;264;264,1	.	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	5758	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3610	199.2	0	.	p	.	0	V596I	NONSYN	1786	1788	GTT	2396	2398	ATT	264;262;260	A,C;T;T	263,1;262;260	.	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	5758	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3610	199.2	1	SNP	p	D86N	0	.	.	256	258	GAC	866	868	GAC	271;272;272	G,A;A;C	270,1;272;272	parC.WHO_F_01444:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	5758	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3610	199.2	1	SNP	p	S87I	0	.	.	259	261	AGT	869	871	AGT	271;272;275	A,C;G;T	270,1;272;275	parC.WHO_F_01444:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	5758	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3610	199.2	1	SNP	p	S87R	0	.	.	259	261	AGT	869	871	AGT	271;272;275	A,C;G;T	270,1;272;275	parC.WHO_F_01444:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	5758	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3610	199.2	1	SNP	p	S87W	0	.	.	259	261	AGT	869	871	AGT	271;272;275	A,C;G;T	270,1;272;275	parC.WHO_F_01444:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	5758	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3610	199.2	1	SNP	p	S88P	0	.	.	262	264	TCC	872	874	TCC	275;276;276	T;C;C	275;276;276	parC.WHO_F_01444:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4886	parE	1986	1986	100.0	parE.l15.c4.ctg.1	3158	192.8	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1752	1754	GGC	268;265;265	G,T,A;G;C	266,1,1;265;265	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.22.001	penA.22.001	1	1	27	4932	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2977	206.8	1	SNP	p	A311V	0	.	.	931	933	GCA	1504	1506	GCA	286;286;290	G;C;A	286;286;290	penA.22.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4932	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2977	206.8	1	SNP	p	I312M	0	.	.	934	936	ATC	1507	1509	ATC	288;287;287	A;T;CAAA,CAA	288;287;277,1	penA.22.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4932	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2977	206.8	1	SNP	p	V316P	0	.	.	946	948	GTG	1519	1521	GTG	291;292;293	G;T,G;G	291;291,1;293	penA.22.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4932	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2977	206.8	1	SNP	p	V316T	0	.	.	946	948	GTG	1519	1521	GTG	291;292;293	G;T,G;G	291;291,1;293	penA.22.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4932	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2977	206.8	1	SNP	p	T484S	0	.	.	1450	1452	ACC	2023	2025	ACC	274;275;273	A,T;C,T;C	272,2;274,1;273	penA.22.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4932	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2977	206.8	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2077	2079	GCG	277;277;271	G,A;C;G	276,1;277;271	penA.22.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4932	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2977	206.8	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2077	2079	GCG	277;277;271	G,A;C;G	276,1;277;271	penA.22.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4932	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2977	206.8	1	SNP	p	G543S	0	.	.	1627	1629	GGT	2200	2202	GGT	297;298;298	G;G;T	297;298;298	penA.22.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4932	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2977	206.8	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2209	2211	GGC	304;303;301	G,C,A;G;C	302,1,1;303;301	penA.22.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4932	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2977	206.8	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2227	2229	CCG	297;300;298	C,T;C,T;G,C	296,1;299,1;296,2	penA.22.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	6068	ponA	2397	2397	100.0	ponA.l6.c30.ctg.1	3488	216.7	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1858	1860	CCG	253;250;247	C,T;C;G,A	252,1;250;246,1	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2710	porA	1146	1146	99.65	porA.l15.c4.ctg.1	2316	146.0	0	.	p	.	0	S22G	NONSYN	64	66	AGC	638	640	GGC	190;186;186	G;G;C	190;186;186	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2710	porA	1146	1146	99.65	porA.l15.c4.ctg.1	2316	146.0	0	.	p	.	0	M83fs	FSHIFT	247	247	A	820	820	C	195	C	195	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3472	porB1b	1047	1047	99.71	porB1b.l6.c4.ctg.1	2245	192.8	0	.	p	.	0	G120D	NONSYN	358	360	GGC	1013	1015	GAC	296;296;297	G,A;A,C,G;C,T	295,1;294,1,1;296,1	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3472	porB1b	1047	1047	99.71	porB1b.l6.c4.ctg.1	2245	192.8	0	.	p	.	0	E145G	NONSYN	433	435	GAA	1088	1090	GGA	285;287;286	G;G;A	285;287;286	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3472	porB1b	1047	1047	99.71	porB1b.l6.c4.ctg.1	2245	192.8	1	SNP	p	A121D	1	.	.	361	363	GAC	1016	1018	GAC	294;291;293	G,T;A,C;C,T	293,1;290,1;292,1	porB1b.WHO_P_02204c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3472	porB1b	1047	1047	99.71	porB1b.l6.c4.ctg.1	2245	192.8	1	SNP	p	D121N	0	.	.	361	363	GAC	1016	1018	GAC	294;291;293	G,T;A,C;C,T	293,1;290,1;292,1	porB1b.WHO_P_02204c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	27	11290	rpoB	4179	4179	100.0	rpoB.l15.c4.ctg.1	5470	257.8	1	SNP	p	H553N	0	.	.	1657	1659	CAT	2313	2315	CAT	283;278;280	C;A,C;T	283;277,1;280	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1756	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1473	148.3	1	SNP	p	V57M	1	.	.	169	171	ATG	725	727	ATG	292;295;294	A,C;T;G	291,1;295;294	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
